Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» QLT Inc. receives Orphan Drug Designation for Visudyne
QLT Inc. receives Orphan Drug Designation for Visudyne
QLT Inc. receives Orphan Drug Designation for Visudyne
Submitted by
admin
on March 19, 2012 - 10:24am
Source:
The Fly on the Wall
News Tags:
orphan drugs
Visudyne
QLT
central serous chorioretinopathy
Headline:
QLT Inc. receives Orphan Drug Designation for Visudyne
Do Not Allow Advertisers to Use My Personal information
